Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00527995Phase 3Completed
Phase 3, randomised, double-blind trial of ASP-001 in endothelial dysfunction (2 arms), sponsored by Ruhr University Bochum. Primary endpoint: Flow Mediated Dilatation at 60 minutes. Started Aug 2001; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00527995.